BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4855735)

  • 1. Abnormalities of cell-mediated immunocompetence in genitourinary cancer.
    Catalona WJ; Chretien PB; Trahan EE
    J Urol; 1974 Feb; 111(2):229-32. PubMed ID: 4855735
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum ribonuclease in urologic cancer. Relation to host immunocompetence.
    Catalona WJ; Chretien PB; Matthews WJ; Tarpley JL
    Urology; 1973 Nov; 2(5):577-81. PubMed ID: 4797457
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic value of host immunocompetence in urologic cancer patients.
    Catalona WJ; Smolev JK; Harty JI
    J Urol; 1975 Dec; 114(6):922-6. PubMed ID: 1195475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic features of genitourinary cancer.
    Javadpour N
    Urology; 1973 Aug; 2(2):103-8. PubMed ID: 4129366
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract.
    Hakala TR; Lange PH; Castro A; Elliott A; Fraley EE
    Cancer; 1974 Dec; 34(6):1929-34. PubMed ID: 4434325
    [No Abstract]   [Full Text] [Related]  

  • 6. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Gerfo PL; Feminella J; Lattimer JK
    J Urol; 1973 Apr; 109(4):699-701. PubMed ID: 4735168
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation among host immunocompetence and tumor stage, tumor grade and vascular permeation in transitional carcinoma.
    Catalona WJ; Chretien PB
    J Urol; 1973 Nov; 110(5):526-8. PubMed ID: 4750895
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunobiology of genitourinary tumors.
    Lange PH; Hakala TR; Fraley EE
    Urology; 1973 Nov; 2(5):485-92. PubMed ID: 4358375
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous response to dinitrochlorobenzene in patients with genito-urinary cancers.
    Duclos H; Schwarzenberg L; Duclos SH; Hugues H; Kuss R
    Biomedicine; 1977 Jan; 27(1):43-7. PubMed ID: 856314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The occurrence of SV40-Neutralizing antibodies in sera of patients with genitourinary carcinoma.
    Shah KV; Palma LD; Murphy GP
    J Surg Oncol; 1971; 3(4):443-50. PubMed ID: 4329010
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cancer associated antigen test as an index to failure of complete removal of urological cancers.
    Wechsler M; Lo Gerfo P; Feminella J; Lattimer JK
    Trans Am Assoc Genitourin Surg; 1972; 64():85-7. PubMed ID: 4347503
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin testing in genitourinary carcinoma: 2-year followup.
    Decenzo JM; Allison R; Leadbetter GW
    J Urol; 1975 Aug; 114(2):271-3. PubMed ID: 1171996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinoembryonic antigen and urothelial carcinoma.
    Hall RR; Laurence DJ; Neville AM; Wallace DM
    Br J Urol; 1973 Feb; 45(1):88-92. PubMed ID: 4690154
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunology of genitourinary tumors.
    Guinan P; Sadoughi N; Bush IM; John T; Eghrari F; Ablin RJ
    Urology; 1973 Nov; 2(5):493-9. PubMed ID: 4131868
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.
    Bean MA; Pees H; FOGH JE; Grabstald H; Oettgen HF
    Int J Cancer; 1974 Aug; 14(2):186-97. PubMed ID: 4477555
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary report of an immunological study in urological cancer.
    Serrallach N; Jimenez JF; Aguiló F; Anguera A; Clavo M; Orejas V; Torner V; Serrate R
    Eur Urol; 1975; 1(2):99-100. PubMed ID: 1241896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.
    Pizza G; De Vinci C
    J Exp Pathol; 1987; 3(4):335-46. PubMed ID: 2457663
    [No Abstract]   [Full Text] [Related]  

  • 20. Carcinoembryonic antigen in patients with tumors of the urogenital tract.
    Reynoso G; Chu TM; Guinan P; Murphy GP
    Cancer; 1972 Jul; 30(1):1-4. PubMed ID: 5064805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.